✦ LIBER ✦

Central pathology review in clinical trials for patients with malignant glioma. A report of radiation therapy oncology group 83-02

✍ Scribed by Charles B. Scott; James S. Nelson; Nancy C. Farnan; Walter J. Curran Jr.; Kevin J. Murray; A. Jennifer Fischbach; Laurie E. Gaspar; Diana F. Nelson

Publisher: John Wiley and Sons
Year: 1995
Tongue: English
Weight: 617 KB
Volume: 76
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19950715)76:2<307::aid-cncr2820760222>3.0.co;2-l

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized trial of accelerated hyperf

A randomized trial of accelerated hyperfractionated radiation therapy and bis-chlorethyl nitrosourea for malignant glioma. A preliminary report of radiation therapy oncology group 83–02

✍ Walter J. Curran Jr.; Charles B. Scott; James S. Nelson; Alan S. Weinstein; Theo 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 862 KB

Final report of a phase I/II trial of hy

Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas: Radiation therapy oncology group study 83-02

✍ Maria Werner-Wasik; Charles B. Scott; Diana F. Nelson; Laurie E. Gaspar; Kevin J 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 825 KB

## BACKGROUND. Efforts to improve local control and survival by increasing the dose of once-daily radiation therapy beyond 70 Gray (Gy) for patients with malignant gliomas have as yet been unsuccessful. Hyperfractionated radiation therapy (HF) should allow for delivery of a higher total dose witho